deferoxamine has been researched along with semaxinib in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Caniggia, I; Groenman, FA; Post, M; Rutter, M; Tibboel, D; Wang, J | 1 |
Butcher, EC; Dahms, P; Gandjeva, A; Granucci, E; Jiang, X; Nicolls, MR; Pasupneti, S; Semenza, GL; Tian, W; Tu, AB; Tuder, RM; Xiang, M | 1 |
3 other study(ies) available for deferoxamine and semaxinib
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Effect of chemical stabilizers of hypoxia-inducible factors on early lung development.
Topics: Amino Acids, Dicarboxylic; Animals; Chlorides; Cobalt; Deferoxamine; Dose-Response Relationship, Drug; Embryo, Mammalian; Epithelial Cells; Ferric Compounds; Hypoxia-Inducible Factor 1; In Vitro Techniques; Indoles; Lung; Mice; Morphogenesis; Neovascularization, Physiologic; Pyrroles; Signal Transduction; Vascular Endothelial Growth Factor Receptor-2 | 2007 |
Endothelial HIF-2α as a Key Endogenous Mediator Preventing Emphysema.
Topics: Angiogenesis Inhibitors; Animals; Basic Helix-Loop-Helix Transcription Factors; Deferoxamine; Disease Models, Animal; Endothelial Cells; Hepatocyte Growth Factor; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Indoles; Iron Chelating Agents; Lung; Mice; Mice, Knockout; Microvessels; Pericytes; Pulmonary Circulation; Pulmonary Disease, Chronic Obstructive; Pulmonary Emphysema; Pyrroles; Smoke | 2020 |